Investors have "never lost money" by choosing smaller companies over larger ones, according to Allianz Global Investors' Andrew Neville.
Standard Life Investments' head of global equities David Cumming has said the group has finally lost patience with banks over bonuses, prompting last week's shock decision to publicly oppose Barclays' remuneration plans.
Former New Star manager Patrick Evershed has reportedly been jeered at Barclays' AGM today after attempting to defend the bank's bonus proposals.
Standard Life Investments has taken the unusual step of criticising Barclays during its AGM, attacking the bank over its latest remuneration proposals amid a fiery meeting.
Franklin Templeton's fixed income head Michael Hasenstab has said Japan's stimulus programme will help support the global recovery and offset tighter monetary policy from the US Federal Reserve.
Alan Custis and Alan Clifford have stuck with insurers amid early signs the sector is rebounding from the sharp falls sparked by Chancellor George Osborne's move to change the pensions landscape.
THE BIG QUESTION: PART II
GlaxoSmithKline, the UK's largest pharmaceutical group, and rival AstraZeneca, saw shares jump sharply - with the latter up 10% - as a series of deals in the sector boosted prices.